-
Mashup Score: 8Increased Biomarker Uptake Needed to Further Realize Potential of Precision Medicine - ILCN.org (ILCN/WCLC) - 1 day(s) ago
Drs. Christian Rolfo and Valeria Denninghoff contend that data show improvements in outcomes from personalized treatment may have stalled and that increased testing for driver genes alterations is needed.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 57Increased Biomarker Uptake Needed to Further Realize Potential of Precision Medicine - ILCN.org (ILCN/WCLC) - 2 day(s) ago
Drs. Christian Rolfo and Valeria Denninghoff contend that data show improvements in outcomes from personalized treatment may have stalled and that increased testing for driver genes alterations is needed.
Source: www.ilcn.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Regulatory News for April 24, 2024 - ILCN.org (ILCN/WCLC) - 4 day(s) ago
US FDA grants accelerated approval of HER2-targeting antibody drug conjugate; China accepts supplemental new drug application for savolitinib.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 14Can Artificial Intelligence Identify Those at High Risk and Shift the Lung Cancer Screening Paradigm? - ILCN.org (ILCN/WCLC) - 8 day(s) ago
In a recent interview, Dr. Lecia V. Sequist, a member of the team behind the Sybil AI algorithm, discusses how technology may soon be able to predict who will develop lung cancer.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 10MARIPOSA-2 Post-progression Analysis Favors Amivantamab-Chemotherapy Combination - ILCN.org (ILCN/WCLC) - 9 day(s) ago
Compared to chemotherapy alone, the addition of the EGFR-MET bispecific antibody significantly prolonged progression-free survival after subsequent therapy, said Dr. Ryan Gentzler during the European Lung Cancer Congress.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7
Dr. Jeffrey D. Bradley presented the data from the phase III study of durvalumab in combination with and following chemoradiotherapy for patients with unresectable, stage III NSCLC during the 2024 European Lung Cancer Congress.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Challenges of Systemic Therapy for Patients with EGFR-mutated Lung Cancer After Progression on Targeted Therapy - ILCN.org (ILCN/WCLC) - 11 day(s) ago
Drs. Christi M.J. Steendam and Sushil K. Badrising review studies comparing outcomes of various treatment regimens in the search for the best-performing approach.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1IASLC Launches Global Member Survey on Diversity, Equity, and Inclusion - ILCN.org (ILCN/WCLC) - 22 day(s) ago
The association seeks input from members to better understand the current DEI landscape so it can continue to build a diverse international community dedicated to the elimination of thoracic malignancies.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5US Food and Drug Administration Accepts New Drug Application for Ensartinib - ILCN.org (ILCN/WCLC) - 23 day(s) ago
The filing was based on results from a global phase III study designed to compare the ALK inhibitor to crizotinib in the first-line treatment of ALK-positive NSCLC.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3The Promise of Artificial Intelligence-Aided Pathology in Thoracic Oncology - ILCN.org (ILCN/WCLC) - 24 day(s) ago
Profs. Jan von der Thüsen and John Le Quesne say while still in the early phases, AI has the potential to bring accessible and affordable prognosis and response prediction tools to all.
Source: www.ilcn.orgCategories: General Medicine News, Onc News and JournalsTweet
Analysis in #ILCN: Drs. @christianrolfo and @VDenninghoff look at the current state of precision medicine in #lungcancer treatment and how to achieve further improvements in survival. https://t.co/k6bvgsUvUm #LCSM